192 related articles for article (PubMed ID: 34240081)
1. Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide Reductase.
Gaur K; Pérez Otero SC; Benjamín-Rivera JA; Rodríguez I; Loza-Rosas SA; Vázquez Salgado AM; Akam EA; Hernández-Matias L; Sharma RK; Alicea N; Kowaleff M; Washington AV; Astashkin AV; Tomat E; Tinoco AD
JACS Au; 2021 Jun; 1(6):865-878. PubMed ID: 34240081
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
Loza-Rosas SA; Vázquez-Salgado AM; Rivero KI; Negrón LJ; Delgado Y; Benjamín-Rivera JA; Vázquez-Maldonado AL; Parks TB; Munet-Colón C; Tinoco AD
Inorg Chem; 2017 Jul; 56(14):7788-7802. PubMed ID: 28644630
[TBL] [Abstract][Full Text] [Related]
3. Applying the Fe(III) binding property of a chemical transferrin mimetic to Ti(IV) anticancer drug design.
Parks TB; Cruz YM; Tinoco AD
Inorg Chem; 2014 Feb; 53(3):1743-9. PubMed ID: 24422475
[TBL] [Abstract][Full Text] [Related]
4. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
[TBL] [Abstract][Full Text] [Related]
5. Excess ribonucleotide reductase R2 subunits coordinate the S phase checkpoint to facilitate DNA damage repair and recovery from replication stress.
Lin ZP; Belcourt MF; Carbone R; Eaton JS; Penketh PG; Shadel GS; Cory JG; Sartorelli AC
Biochem Pharmacol; 2007 Mar; 73(6):760-72. PubMed ID: 17188250
[TBL] [Abstract][Full Text] [Related]
6. Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs.
Plamthottam S; Sun D; Van Valkenburgh J; Valenzuela J; Ruehle B; Steele D; Poddar S; Marshalik M; Hernandez S; Radu CG; Zink JI
J Biol Inorg Chem; 2019 Aug; 24(5):621-632. PubMed ID: 31250199
[TBL] [Abstract][Full Text] [Related]
7. Function and regulation of yeast ribonucleotide reductase: cell cycle, genotoxic stress, and iron bioavailability.
Sanvisens N; de Llanos R; Puig S
Biomed J; 2013; 36(2):51-8. PubMed ID: 23644233
[TBL] [Abstract][Full Text] [Related]
8. Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.
Saxena M; Loza-Rosas SA; Gaur K; Sharma S; Pérez Otero SC; Tinoco AD
Coord Chem Rev; 2018 May; 363():109-125. PubMed ID: 30270932
[TBL] [Abstract][Full Text] [Related]
9. Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis.
Tebbi A; Guittet O; Tuphile K; Cabrié A; Lepoivre M
J Biol Chem; 2015 May; 290(22):14077-90. PubMed ID: 25878246
[TBL] [Abstract][Full Text] [Related]
10. A stable FeIII-FeIV replacement of tyrosyl radical in a class I ribonucleotide reductase.
Voevodskaya N; Lendzian F; Gräslund A
Biochem Biophys Res Commun; 2005 May; 330(4):1213-6. PubMed ID: 15823572
[TBL] [Abstract][Full Text] [Related]
11. The diferric-tyrosyl radical cluster of ribonucleotide reductase and cytosolic iron-sulfur clusters have distinct and similar biogenesis requirements.
Li H; Stümpfig M; Zhang C; An X; Stubbe J; Lill R; Huang M
J Biol Chem; 2017 Jul; 292(27):11445-11451. PubMed ID: 28515324
[TBL] [Abstract][Full Text] [Related]
12. Branched activation- and catalysis-specific pathways for electron relay to the manganese/iron cofactor in ribonucleotide reductase from Chlamydia trachomatis.
Jiang W; Saleh L; Barr EW; Xie J; Gardner MM; Krebs C; Bollinger JM
Biochemistry; 2008 Aug; 47(33):8477-84. PubMed ID: 18656954
[TBL] [Abstract][Full Text] [Related]
13. Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase.
Sengupta R; Coppo L; Mishra P; Holmgren A
J Biol Chem; 2019 Aug; 294(34):12708-12716. PubMed ID: 31266802
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of chlamydial class Ic ribonucleotide reductase by C-terminal peptides from protein R2.
Ohrström M; Popović-Bijelić A; Luo J; Stenmark P; Högbom M; Gräslund A
J Pept Sci; 2011 Nov; 17(11):756-62. PubMed ID: 21976435
[TBL] [Abstract][Full Text] [Related]
15. Reduced level of ribonucleotide reductase R2 subunits increases dependence on homologous recombination repair of cisplatin-induced DNA damage.
Lin ZP; Lee Y; Lin F; Belcourt MF; Li P; Cory JG; Glazer PM; Sartorelli AC
Mol Pharmacol; 2011 Dec; 80(6):1000-12. PubMed ID: 21875941
[TBL] [Abstract][Full Text] [Related]
16. A docking model of human ribonucleotide reductase with flavin and phenosafranine.
Priya PL; Shanmughavel P
Bioinformation; 2009 Sep; 4(3):123-6. PubMed ID: 20198185
[TBL] [Abstract][Full Text] [Related]
17. Structure, function, and mechanism of ribonucleotide reductases.
Kolberg M; Strand KR; Graff P; Andersson KK
Biochim Biophys Acta; 2004 Jun; 1699(1-2):1-34. PubMed ID: 15158709
[TBL] [Abstract][Full Text] [Related]
18. Chlamydial ribonucleotide reductase: tyrosyl radical function in catalysis replaced by the FeIII-FeIV cluster.
Voevodskaya N; Narvaez AJ; Domkin V; Torrents E; Thelander L; Gräslund A
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9850-4. PubMed ID: 16777966
[TBL] [Abstract][Full Text] [Related]
19. Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts.
Lembo D; Gribaudo G; Hofer A; Riera L; Cornaglia M; Mondo A; Angeretti A; Gariglio M; Thelander L; Landolfo S
J Virol; 2000 Dec; 74(24):11557-65. PubMed ID: 11090153
[TBL] [Abstract][Full Text] [Related]
20. Allosteric effectors are required for subunit association in T4 phage ribonucleotide reductase.
Hanson E; Mathews CK
J Biol Chem; 1994 Dec; 269(49):30999-1005. PubMed ID: 7983036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
